He attended medical school and postgraduate training at Louisiana State University in New Orleans. After receiving his Doctorate in Medicine (M.D.), he completed a surgical internship in General Surgery at Charity Hospital and lived in New Orleans during Hurricane Katrina. In 2007, he completed his oral and maxillofacial surgery residency at Louisiana State University, one of the top programs in the country. His residency provided extensive training and exposure to all facets of oral and maxillofacial surgery, including corrective facial and orthognathic surgery, dental implants, dentoalveolar and temporomandibular joint surgery, bone grafting, complex facial trauma and reconstruction, oral pathology, and facial cosmetic surgery.
As a diplomat of the American Board of Oral and Maxillofacial Surgery (AAOMS), Dr. Ryser has been elected by his peers to represent oral surgeons in the state of Utah in the House of Delegates at the national level. As a standout in the House of Delegates, he has been asked by the national leadership of AAOMS to also serve on the committee of Continuing Education and Professional Development (CCEPD). He also serves on the anesthesia committee for the Utah Association of Oral and Maxillofacial Surgery (UAOMS) and was asked to sit on the Western Society of Oral and Maxillofacial Surgery’s Board of Directors. He was recently asked to serve as the Medical Director for Specialty Dental Brands.
Additionally, Dr. Ryser has received multiple awards at national and international meetings for his research and publications in dental implants and craniofacial biology. He practices the entire scope of oral and maxillofacial surgery with a particular interest in dental implants, with a special focus on digital workflows and 3D-printed guided surgery. Other areas of special interest include orthognathic surgery and facial and peri-oral cosmetic surgery. He has acted as a sub-Investigator on multiple clinical trials for post-op pain following third molar extraction. Clinical trial experience includes phase II, phase III, and a pivotal phase III trial with the drug receiving FDA approval and is currently available over the counter.
When he isn't providing top-quality care to patients, Dr. Ryser loves spending time with his wife and family. He also enjoys riding dirt bikes outdoors with his son and Aspire partners and working in his yard.